The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.

FDA said the document expands on devices, including gaseous-phase carbon-dioxide gas analyzers, which include capnographs and devices with capnography features.

FDA yesterday also approved two generic injectable drugs to facilitate tracheal intubation: succinylcholine chloride and cisatracurium besylate. These drugs are intended to help meet the demand for skeletal muscle relaxation during surgery or mechanical ventilation during the COVID-19 emergency.

Related News Articles

Headline
The Centers for Disease Control and Prevention today announced shorter quarantine options based on local circumstances and resources, for people exposed to the…
Headline
The AHA today launched a new periodic report to convey to congressional staff hospitals’ and health systems’ desperate need for a new COVID-19 relief package…
Headline
Reps. Bradley Schneider, D-Ill., and David McKinley, R-W.Va., today introduced the Medicare Sequester COVID Moratorium Act, AHA-supported legislation that…
Headline
An independent advisory group for the Centers for Disease Control and Prevention yesterday recommended health care personnel and long-term care facility…
Headline
The Department of Health and Human Services should provide greater flexibility around health care staffing, provider resource allocation and accessibility to…
Headline
The Senate Homeland Security and Governmental Affairs Committee today held a hearing on defending communities from cyber threats during the COVID-19 pandemic…